Top 10 Pot Stocks to Invest in 2019

Cannabis Blog Posted 7 months ago
image

It wasn’t long ago when investments in marijuana were associated with a violation of the law. But times have changed and now we are witnessing the development of the cannabis market throughout different countries. Canada became the second country in the world and the first country of the Group of 7 that completely legalized cannabis for recreational use. 28 states have legalized the use of medical marijuana while 8 states have legalized the use of recreational medical marijuana in America. Changes in social attitude and increasing level of acceptability have a positive impact on the cannabis industry.

There is no denying that the rate of MJ stocks has grown over the last few years and such a trend is gaining momentum. As medical marijuana continues to become more accepted and legalized, medical MJ stocks will continue to gain popularity and recognition from the rest of the stock market. If you are interested in gaining profit from the booming cannabis industry, then one way to do it is to invest in promising marijuana-related companies. Below we listed the companies, which stocks are worth purchasing.

1. Aleafia Health (ALEAF)

Aleafia Health, a Canadian vertically integrated cannabis company, operates medical clinics, cultivation and research and development divisions. Aleafia Health has been named the TMX Group’s 2019 TSX Venture 50 top performing company of the year amongst all 2,000 TSX Venture Exchange listed companies. The award was based on three equally weighted criteria: market capitalization growth, and share price appreciated and trading volume. This is the first time a cannabis company has achieved top performing status. For more information visit Aleafia Health page.

2. MediPharm Labs (MLCPF)

A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies, and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products. In March 2018, MediPharm Labs received its cannabis oil production license from Health Canada and have been extracting in Ontario since June 2018. MediPharm Labs has also launched in Australia, and pending Office of Drug Control Australia approval will soon be producing cannabis oil. To learn more follow MediPharm Labs.

3. Aurora Cannabis (ACB)

Aurora Cannabis Inc. is a Canadian licensed cannabis producer. The company promotes the idea that medical cannabis should not be costly, inconsistent, or difficult to access. As of late September 2018, the company had eight licensed production facilities, five sales licenses, and operations in 18 countries. It had a funded capacity of over 500,000 kilograms of cannabis production per annum. Aurora is the second largest cannabis company in the world by market capitalization, after Canopy Growth Corporation. The company began trading on the NYSE on October 23rd, 2018. To see more visit Aurora Cannabis page.

4. Green Organic Dutchman Holdings (TGODF)

The Green Organic Dutchman, headquartered in Mississauga, Ontario, is a cannabis industry company listed on the Toronto Stock Exchange. Company's philosophy is more than growing certified organic cannabis; it's cultivating a way of life.  TGOD is a consumer-oriented business and they truly believe that cultivating organically is the best way to provide consumers with safe, high-quality, products. The initial public offering (IPO), completed on May 2, 2018, was the industry's largest to date and raised over CAD$115 million. The company's prospectus listed cannabis tourism from U.S. consumers, low power rates, and its large greenhouses as competitive advantages. Find more information at Green Organic Dutchman Holdings.

5. Plus Products (PLPRF)

Plus Products Inc. is a branded products manufacturer based in California. Its products consist of cannabis-infused edibles, which it sells to both the regulated medicinal and adult-use recreational markets. PLUSTM is currently one of the fastest-growing edible brands in California with the State’s top-selling products. The Company’s mission is to make cannabis safe and approachable – that starts with manufacturing high-quality products and delivering consistent experiences. For more visit https://www.plusproducts.com/

6. Liberty Health Sciences (LHSIF)

With origins in a highly-regulated cannabis market like Canada, Liberty Health Sciences brings expertise and progressive approaches to cannabis products for customers in the United States. In 2018, Liberty Health Sciences scored the highest GMP audit score of all Florida dispensaries. Its LHS 360º Innovation Center in Gainesville, FL is slated for buildout and will contain 180,000sf of cannabis greenhouse facilities. Liberty Health Sciences cannabis products are pharmaceutical-grade and are the result of thousands of hours of formulating, testing, and optimizing to bring its customers the cream of the crop. Learn more at Liberty Health Sciences.

7. 1933 Industries (TFIFF)

1933 Industries is a Canadian public company, which owns and controls cannabis and hemp-based assets in Las Vegas Nevada as well as a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company owns 91% of Alternative Medicine Association, LC (AMA), and a licensed medical and adult-use cannabis cultivation and production facility that produces its own line of unique cannabis-based products and manufactures other third-party brands. Infused MFG, also a 91% owned subsidiary, produces hemp-based, CBD products, thoughtfully crafted of high quality organic botanical ingredients. To see more visit 1933 Industries page.

8. Canopy Growth Corp. (CGC)

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario. Canopy Growth was the first to introduce the now-standard concept of Compassionate Pricing to make medical cannabis affordable for patients. They were also the first Canadian producer to be approved to export dried cannabis to Germany. Canopy Growth was a leader in striking a strategic relationship with a Fortune 500 beverage alcohol supplier to bring exciting new products to market. In May 2018, it was listed on the New York Stock Exchange. Find more information at Canopy Growth Corp. page.

9. Cronos Group (CRON)

Cronos Group is an innovative Canadian cannabinoid company. With international production and distribution across five continents, Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global health and wellness platform, and two adult-use brands COVE™ and Spinach™. To learn more visit Cronos Group page.

10. Tilray (TLRY)

Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States. It was the first medical cannabis producer in North America to be GMP certified. In September 2018, Tilray became the first Canadian cannabis company to legally export medical cannabis to the U.S. for a clinical trial. In 2018, they announced the launch of High Park Company which would operate in the adult recreational cannabis market to establish unique adult-use brands in Canada upon its legalization. Tilray made history by being the first cannabis company to debut on a major U.S. stock exchange in July 2018. According to Renaissance Capital, TLRY is the top 10 performers in the U.S. stock market. See more at Tilray.

These 10 are just a small part of the long list of successful and thriving cannabis companies worth investing in. We advise you to visit Infuzes Cannabis Indexes service, where anyone interested can get information about stock exchange happenings and check out top cannabis-related companies. It should be noted that this article only expresses the author's opinion, which is based on market analysis, and it shouldn't be considered as financial advise or an urge to invest.